Brought to you by 
Polaris leads $5mm Series A round for SQZ Biotechnologies
02 Jul 2015
Executive Summary
Cell engineering start-up SQZ Biotechnologies Co. raised $5mm in Series A financing. According to the Form D filing, 22 investors participated, including Polaris Partners (lead) and 20/20 Healthcare Partners.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
-
Drug Delivery
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Polaris leads $5mm Series A round for SQZ Biotechnologies
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice